Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Blood
|
August 24, 2014
CLEC-2 expression is maintained on activated platelets and on platelet microparticles
Eelo Gitz, Alice Y Pollitt, Jerney J Gitz-Francois, et al.
Nature Communications
|
June 2, 2015
Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex
Natalie S Poulter, Alice Y Pollitt, Amy Davies, et al.
The Biochemical Journal
|
April 8, 2015
Activation of glycoprotein VI (GPVI) and C-type lectin-like receptor-2 (CLEC-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands
Osama M Alshehri, Samantha Montague, Stephanie Watson, et al.
The Journal of Biological Chemistry
|
November 5, 2014
Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells
Alice Y Pollitt, Natalie S Poulter, Eelo Gitz, et al.
Thrombosis and Haemostasis
|
February 16, 2022
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist
Luis A Morán, Ying Di, Marcin A Sowa, et al.
Haematologica
|
July 21, 2018
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
Phillip L R Nicolson, Craig E Hughes, Stephanie Watson, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 5, 2019
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation
Joanne L Dunster, Amanda J Unsworth, Alexander P Bye, et al.
The Journal of Experimental Medicine
|
February 4, 2015
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Ulrike Flierl, Tracy L Nero, Bock Lim, et al.
Communications Biology
|
April 7, 2023
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists
Joanne C Clark, Eleyna M Martin, Luis A Morán, et al.
Blood
|
December 22, 2011
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development
Brenda A Finney, Edina Schweighoffer, Leyre Navarro-Núñez, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Blood
|
August 24, 2014
CLEC-2 expression is maintained on activated platelets and on platelet microparticles
Eelo Gitz, Alice Y Pollitt, Jerney J Gitz-Francois, et al.
Nature Communications
|
June 2, 2015
Platelet actin nodules are podosome-like structures dependent on Wiskott-Aldrich syndrome protein and ARP2/3 complex
Natalie S Poulter, Alice Y Pollitt, Amy Davies, et al.
The Biochemical Journal
|
April 8, 2015
Activation of glycoprotein VI (GPVI) and C-type lectin-like receptor-2 (CLEC-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands
Osama M Alshehri, Samantha Montague, Stephanie Watson, et al.
The Journal of Biological Chemistry
|
November 5, 2014
Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells
Alice Y Pollitt, Natalie S Poulter, Eelo Gitz, et al.
Thrombosis and Haemostasis
|
February 16, 2022
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist
Luis A Morán, Ying Di, Marcin A Sowa, et al.
Haematologica
|
July 21, 2018
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI
Phillip L R Nicolson, Craig E Hughes, Stephanie Watson, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 5, 2019
Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation
Joanne L Dunster, Amanda J Unsworth, Alexander P Bye, et al.
The Journal of Experimental Medicine
|
February 4, 2015
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Ulrike Flierl, Tracy L Nero, Bock Lim, et al.
Communications Biology
|
April 7, 2023
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists
Joanne C Clark, Eleyna M Martin, Luis A Morán, et al.
Blood
|
December 22, 2011
CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development
Brenda A Finney, Edina Schweighoffer, Leyre Navarro-Núñez, et al.
Page
of 4